BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24357632)

  • 1. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
    Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
    J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion.
    Tóth I; Le AQ; Hartjen P; Thomssen A; Matzat V; Lehmann C; Scheurich C; Beisel C; Busch P; Degen O; Lohse AW; Eiermann T; Fätkenheuer G; Meyer-Olson D; Bockhorn M; Hauber J; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2013 Oct; 94(4):551-61. PubMed ID: 23709688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
    Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
    J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
    Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
    Techakriengkrai N; Tansiri Y; Hansasuta P
    AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Panigrahi S; Bazdar DA; Albakri M; Ferrari B; Antonelli CJ; Freeman ML; Dubyak G; Zender C; Sieg SF
    Eur J Immunol; 2020 Dec; 50(12):2055-2066. PubMed ID: 32548862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
    Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.
    Christensen LD; Andersen V; Ryder L
    Scand J Immunol; 1996 Jul; 44(1):62-70. PubMed ID: 8693293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals.
    Shahbaz S; Okoye I; Blevins G; Elahi S
    PLoS Pathog; 2022 Mar; 18(3):e1010378. PubMed ID: 35325005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
    Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
    Resta R; Hooker SW; Laurent AB; Shuck JK; Misumi Y; Ikehara Y; Koretzky GA; Thompson LF
    J Immunol; 1994 Aug; 153(3):1046-53. PubMed ID: 8027539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.
    Lichterfeld M; Yu XG; Mui SK; Williams KL; Trocha A; Brockman MA; Allgaier RL; Waring MT; Koibuchi T; Johnston MN; Cohen D; Allen TM; Rosenberg ES; Walker BD; Altfeld M
    J Virol; 2007 Apr; 81(8):4199-214. PubMed ID: 17287271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
    López M; Soriano V; Peris-Pertusa A; Rallón N; Restrepo C; Benito JM
    AIDS Res Hum Retroviruses; 2011 Feb; 27(2):157-65. PubMed ID: 20964478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.